Multiple Sclerosis (MS) as other well recognized immunologically mediated diseases have a strong female predominance. Endocrine and immunological aspects are relevant where estrogens specifically estriol at a high dose…
disease modifying therapies for the treatment of multiple sclerosis, there are still patients who suffer from severe neurological dysfunction in the relapsing-remitting or early progressive forms of the disease ... cell…
Interferon-β has therapeutic efficacy in Multiple Sclerosis by reducing disease exacerbations and delaying relapses. Previous studies have suggested that the effects of type I IFN in Experimental Autoimmune…
transverse myelitis. NMO typically has a worse prognosis than multiple sclerosis due the severity of the acute relapses which lead significant visual and motor impairment. Although the discovery
Multiple sclerosis is an inflammatory, demyelinating disease of the central nervous system. Most patients have a relapsing-remitting disease type, for which medicines are mostly dedicated. Clinical course of some…
treatment challenging. In particular, distinguishing MOGAD from multiple sclerosis (MS) is important for adequate treatment and the prevention of relapsing disease. In this report, we present a rare case ... analysis at…
machinery as an innovative strategy to suppress MS. Benign multiple sclerosis (BMS) occurs in about 15% of patients with relapsing-remitting MS (RRMS) that over time do not develop significant
Multiple Sclerosis (MS) is a neuroinflammatory and immune-mediated chronic disease of the Central Nervous System which progressively damages the axonal myelin sheath, leading to axonal transmission impairment…
Cognitive abnormalities are frequently observed in advanced stages of Multiple Sclerosis (MS). Their frequency increases from clinically isolated syndromes, to relapsing-remitting and secondary progressive MS. The most…
differentiate between grief and depression in patients with multiple sclerosis (MS) and to compare the two types of MS; Remitting Relapsing MS (RRMS) and progressive MS (PMS) as regards hopelessness
wrong diagnosis of patients as being affected with multiple sclerosis for many years due to MRI abnormalities rather than classical relapsing remitting nature of the disease may lead to grave
similar or different mechanisms contribute to different subtypes of multiple sclerosis (MS). A unifying concept proposes that patients with both relapsing-remitting MS (RRMS) and primary progressive MS (PPMS) have
Introduction: Multiple sclerosis is a chronic neurological disease that manifests clinically in many different ways, causing varying degrees of disability. This disease has been addressed for years as the result…
Introduction: Multiple sclerosis (MS) is the main demyelinating inflammatory disease of the central nervous system. It usually affects young female adults between 20 and 40 years old, during professional activity…
Introduction: Monoclonal antibodies (MABs) are one of the preferred treatments for multiple sclerosis (MS) due to their target specificity and usually high efficacy. These have usually targeted the immune system…
effect, we used a murine model for multiple sclerosis, the experimental autoimmune encephalomyelitis (EAE) induction, using MOG35-55 immunization with a relapsing-remitting course. AMSCs were previously treated with LPA1
treating Multiple Sclerosis (MS), with the number now exceeding 15 options, including various dosages and generics. However, while these treatments have primarily targeted the inflammatory activity underlying relapses…
Treatment of Multiple Sclerosis (MS) has received substantial attention due to devastating symptoms, disability progression, mental health and cost of polytherapy. To investigate the effect of vitamin D supplementation…
placebo or other modalities of multiple sclerosis (comparators), for the non-inferiority or superiority in terms of effects on walk, disability, relapse and/or other disease clinical markers (outcome
Multiple Sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system, marked by progressive disability and relapses. This article explores the physical, emotional, and social challenges faced
Relationship between antiphospholipid antibodies (aPL) and multiple sclerosis (MS) is still. To evaluate a link between aPL and MS a retrorespective study on patients whose were referred to a clinical ... during disease…
Progressive multiple sclerosis (MS) is characterized by the accumulation of disability over time that may follow a period of clinical relapses (secondary progressive MS) or appear since onset (primary progressive
Background: This Multiple Sclerosis (MS) is a Central Nervous System (CNS) disease characterized by demyelination or axonal loss encompassing several clinical subtypes—Relapsing-Remitting MS (RRMS)…
stimulated mast cells do survive and within weeks/months may fully reload (5). Stimulation (relapsing phase), time for reloading (remitting phase), and so on. Recent Publications 1. Neumann ... für klinische Medicin…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.